메뉴 건너뛰기
Clinical Cancer Research
Volumn 12, Issue 15, 2006, Pages 4784-
Genetic effect of ERCC1 codon 118 polymorphism and confounding factors [1]
Author keywords

[No Author keywords available]
Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; PLATINUM;
EID: 33748070812     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0419     Document Type: Letter
Times cited : (5)
References (6)
  • 1
    • 24344479165 scopus 로고    scopus 로고
    • ERCC1 codon 118 polymorphism is a predictive factor for the tumor response tooxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer
    • Viguier J, Boige V, Miquel C, et al. ERCC1 codon 118 polymorphism is a predictive factor for the tumor response tooxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer. Clin Cancer Res 2005; 11:6212-7.
    • (2005) Clin Cancer Res , vol.11 , pp. 6212-6217
    • Viguier, J.1    Boige, V.2    Miquel, C.3
  • 2
    • 2342616723 scopus 로고    scopus 로고
    • Association between polymorphisms of ERCC1 and XPD and survival in non-small cell lung cancer patients treated with cisplatin combination chemotherapy
    • Ryu JS, Hong YC, Man HS, et al. Association between polymorphisms of ERCC1 and XPD and survival in non-small cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer 2004;44:311-6.
    • (2004) Lung Cancer , vol.44 , pp. 311-316
    • Ryu, J.S.1    Hong, Y.C.2    Man, H.S.3
  • 3
    • 4143051317 scopus 로고    scopus 로고
    • Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non small cell lung cancer patients treated with platinum based chemotherapy
    • Zhou W, Gurubhagavatula S, Liu G, et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non small cell lung cancer patients treated with platinum based chemotherapy. Clin Cancer Res 2004;10:4939-43.
    • (2004) Clin Cancer Res , vol.10 , pp. 4939-4943
    • Zhou, W.1    Gurubhagavatula, S.2    Liu, G.3
  • 4
    • 4444256594 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms and outcome in docetaxel cisplatin treated advanced non-small cell lung cancer
    • Isla D, Sarries C, Rosell R, et al. Single nucleotide polymorphisms and outcome in docetaxel cisplatin treated advanced non-small cell lung cancer. Ann Oncol 2004; 15:1194-203.
    • (2004) Ann Oncol , vol.15 , pp. 1194-1203
    • Isla, D.1    Sarries, C.2    Rosell, R.3
  • 5
    • 13944275920 scopus 로고    scopus 로고
    • Gene smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer
    • Zhou W, Liu G, Park S, et al. Gene smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005;14:491-6.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 491-496
    • Zhou, W.1    Liu, G.2    Park, S.3
  • 6
    • 33846996411 scopus 로고    scopus 로고
    • Effect of ERCD polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    • In press
    • Park SY, Hong YC, Kim JH, et al. Effect of ERCD polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients. Med Oncol U S A. In press 2006.
    • (2006) Med Oncol U S A
    • Park, S.Y.1    Hong, Y.C.2    Kim, J.H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.